Nadal Angel, Ropero Ana B, Fuentes Esther, Soria Bernat, Ripoll Cristina
Institute of Bioengineering, Miguel Hernández University, San Juan Campus, Carretera Alicante-Valencia Km 87, Alicante 03550, Spain.
Steroids. 2004 Aug;69(8-9):531-6. doi: 10.1016/j.steroids.2004.05.010.
17beta-Estradiol elicits a rapid opposite effect on [Ca2+]i in alpha- and beta-cells within intact islets of Langerhans. In beta-cells, physiological concentrations of the gonadal hormone decreases KATP channel activity in synergy with glucose, leading to a membrane depolarization that opens voltage-gated Ca2+ channels, potentiating Ca2+ signals. As a consequence insulin release is enhanced and transcription factor CREB is activated in a Ca(2+)-dependent manner. In glucagon-containing alpha-cells, 17beta-estradiol provokes the abolishment of Ca2+ oscillations generated by low glucose, a situation that should decrease glucagon release. In both types of cells the second messenger involved is cGMP. The estrogen receptor involved is located in the plasma membrane and has a pharmacological profile unrelated to classical estrogen receptors ERalpha and ERbeta. For that reason, it has been named non-classical membrane estrogen receptor (ncmER). Although the physiological roles of this receptor are still unknown, it may be implicated in the responses of the endocrine pancreas to the physiological and pathological changes of 17beta-estradiol.
17β-雌二醇对完整胰岛中的α细胞和β细胞内的[Ca2+]i产生快速相反的作用。在β细胞中,生理浓度的性腺激素与葡萄糖协同降低KATP通道活性,导致膜去极化,从而打开电压门控Ca2+通道,增强Ca2+信号。结果,胰岛素释放增加,转录因子CREB以Ca(2+)依赖的方式被激活。在含胰高血糖素的α细胞中,17β-雌二醇促使低葡萄糖产生的Ca2+振荡消失,这种情况会减少胰高血糖素的释放。在这两种细胞类型中,所涉及的第二信使都是cGMP。所涉及的雌激素受体位于质膜,其药理学特性与经典雌激素受体ERα和ERβ无关。因此,它被命名为非经典膜雌激素受体(ncmER)。尽管该受体的生理作用仍不清楚,但它可能参与内分泌胰腺对17β-雌二醇生理和病理变化的反应。